These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27426453)

  • 41. A mass spectrometer-compatible liquid chromatographic method for the analysis of tylosin and its impurities using a superficially porous particle column.
    Lin Q; de Waal T; Van Schepdael A; Adams E
    J Pharm Biomed Anal; 2019 Feb; 165():147-154. PubMed ID: 30544049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reversed-phase liquid chromatography separation and mass spectrometry fragmentation analysis of mitiglinide and three isomers].
    Li M; Liu H; Hou J; Wang C; Li W; Che B
    Se Pu; 2019 Apr; 37(4):412-417. PubMed ID: 30977344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Separation and characterization of unknown impurities in cefonicid sodium by trap-free two-dimensional liquid chromatography combined with ion trap time-of-flight mass spectrometry.
    Wang J; Xu Y; Zhang Y; Wang H; Zhong W
    Rapid Commun Mass Spectrom; 2017 Sep; 31(18):1541-1550. PubMed ID: 28688234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of impurities in polymyxin B and colistin bulk sample using liquid chromatography coupled to mass spectrometry.
    Van den Bossche L; Van Schepdael A; Chopra S; Hoogmartens J; Adams E
    Talanta; 2011 Feb; 83(5):1521-9. PubMed ID: 21238747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of the polymerized impurities in cefmetazole sodium based on novel separation principle by liquid chromatography tandem ion trap/time-of-flight mass spectrometry.
    Wang F; Ren X; Zhu B; Zhang F; Gao J; Hong L; Wang J
    J Pharm Biomed Anal; 2022 Jun; 215():114790. PubMed ID: 35483231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectrometric detection.
    Zhang X; Zhai S; Zhao R; Ouyang J; Li X; Baeyens WR
    Anal Chim Acta; 2007 Sep; 600(1-2):142-6. PubMed ID: 17903476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR.
    Awasthi A; Razzak M; Al-Kassas R; Greenwood DR; Harvey J; Garg S
    Anal Bioanal Chem; 2012 Nov; 404(8):2203-22. PubMed ID: 22986987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry.
    Chen Z; Zhu X; Geng Y; Dai J; Tang S; Adams E; Chen D; Yuan Y
    J Pharm Biomed Anal; 2022 Nov; 221():115061. PubMed ID: 36183632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An enhanced targeted identification strategy for the selective identification of flavonoid O-glycosides from Carthamus tinctorius by integrating offline two-dimensional liquid chromatography/linear ion-trap-Orbitrap mass spectrometry, high-resolution diagnostic product ions/neutral loss filtering and liquid chromatography-solid phase extraction-nuclear magnetic resonance.
    Yao CL; Yang WZ; Si W; Shen Y; Zhang NX; Chen HL; Pan HQ; Yang M; Wu WY; Guo DA
    J Chromatogr A; 2017 Mar; 1491():87-97. PubMed ID: 28256254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impurity profiling of micronomicin sulfate injection by liquid chromatography-ion trap mass spectrometry.
    Yuan YZ; Zhao X; Zhang M; Fan XL; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Mar; 75():94-104. PubMed ID: 23261805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rapid characterization of impurities in the bulk drug of nifedipine by high performance liquid chromatography-quadrupole time of fight mass spectrometry].
    Zhu P; Ding L; He J; Zheng G
    Se Pu; 2012 Oct; 30(10):1026-30. PubMed ID: 23383491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of impurities in tylosin using dual liquid chromatography combined with ion trap mass spectrometry.
    Chopra S; Van Schepdael A; Hoogmartens J; Adams E
    Talanta; 2013 Mar; 106():29-38. PubMed ID: 23598092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of impurities in spiramycin by liquid chromatography/ion trap mass spectrometry.
    Pendela M; Govaerts C; Diana J; Hoogmartens J; Van Schepdael A; Adams E
    Rapid Commun Mass Spectrom; 2007; 21(4):599-613. PubMed ID: 17262895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of non-steroidal anti-inflammatory drugs in milk using QuEChERS and liquid chromatography coupled to mass spectrometry: triple quadrupole versus Q-Orbitrap mass analyzers.
    Rúbies A; Guo L; Centrich F; Granados M
    Anal Bioanal Chem; 2016 Aug; 408(21):5769-5778. PubMed ID: 27325465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of impurities in josamycin using dual liquid chromatography combined with mass spectrometry.
    Van den Bossche L; Daidone F; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Jan; 73():66-76. PubMed ID: 22326844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An integrated approach for detection and characterization of the trace impurities in levofloxacin using liquid chromatography-tandem mass spectrometry.
    Zheng YJ; He JM; Zhang RP; Wang YC; Wang JX; Wang HQ; Wu Y; He WY; Abliz Z
    Rapid Commun Mass Spectrom; 2014 May; 28(10):1164-74. PubMed ID: 24711279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.